Literature DB >> 15772231

Atherosclerotic renal artery stenosis, ACE inhibitors, and avoiding cardiovascular death.

John Main1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15772231      PMCID： PMC1768825          DOI： 10.1136/hrt.2003.019505

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  23 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

Review 2.  The renin-angiotensin system as a risk factor and therapeutic target for cardiovascular and renal disease.

Authors:  Massimo Volpe; Carmine Savoia; Paola De Paolis; Beata Ostrowska; David Tarasi; Speranza Rubattu
Journal:  J Am Soc Nephrol       Date:  2002-11       Impact factor: 10.121

Review 3.  Arteriosclerotic renal artery stenosis: conservative versus interventional management.

Authors:  Christlieb Haller
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

Review 4.  Renal dysfunction complicating the treatment of hypertension.

Authors:  Biff F Palmer
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

Review 5.  Chronic renal ischemia: implications for cardiovascular disease risk.

Authors:  Timothy P Murphy; John H Rundback; Christopher Cooper; M Susan Kiernan
Journal:  J Vasc Interv Radiol       Date:  2002-12       Impact factor: 3.464

6.  Individual kidney function in atherosclerotic nephropathy is not related to the presence of renal artery stenosis.

Authors:  C K Farmer; G J Cook; G M Blake; J Reidy; J E Scoble
Journal:  Nephrol Dial Transplant       Date:  1999-12       Impact factor: 5.992

7.  Incidental renal artery stenosis in peripheral vascular disease: a case for treatment?

Authors:  T C Leertouwer; P M Pattynama; A van den Berg-Huysmans
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

8.  Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography.

Authors:  P J Conlon; M A Little; K Pieper; D B Mark
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

9.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

10.  A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease.

Authors:  Julian R Wright; Ala'a E Shurrab; Ching Cheung; Steven Waldek; Donal J O'Donoghue; Robert N Foley; Hari Mamtora; Philip A Kalra
Journal:  Am J Kidney Dis       Date:  2002-06       Impact factor: 8.860
View more
  3 in total

Review 1.  [Hypertension in patients with renal artery stenosis].

Authors:  A Voiculescu; L C Rump
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

Review 2.  Angiotensin-converting enzyme inhibitors and receptor blockers in heart failure and chronic kidney disease - Demystifying controversies.

Authors:  Kader Muneer; Anishkumar Nair
Journal:  Indian Heart J       Date:  2016-09-08

3.  Renal artery stenosis presenting with nephrotic-range proteinuria: a case report.

Authors:  Subin Hwang; Jun Soo Ham; Keum Bit Hwang; Suk Hyeon Jeong; Sung Hae Ha; Eun Hee Koo; Ghee Young Kwon; Young Soo Do; Hye Ryoun Jang
Journal:  Kidney Res Clin Pract       Date:  2015-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.